Please login to the form below

Not currently logged in
Email:
Password:

lasmiditan

This page shows the latest lasmiditan news and features for those working in and with pharma, biotech and healthcare.

Lilly set to head to regulators with CGRP migraine drug

Lilly set to head to regulators with CGRP migraine drug

Lilly recently added to its galcanezumab programme in migraine by buying CoLucid and its lead drug lasmiditan, an oral serotonin 5-HT 1F agonist that is due to be filed for

Latest news

  • Lilly to buy migraine drug developer CoLucid for $960m Lilly to buy migraine drug developer CoLucid for $960m

    Lilly to buy migraine drug developer CoLucid for $960m. Deal revolves around lasmiditan, which the firm out-licensed in 2005. ... Lasmiditan's different mechanism means it could become the first drug that works without vasoconstriction, according to Lilly

  • Migraine drugs' headache Migraine drugs' headache

    CoLucid Pharmaceuticals is developing lasmiditan, which specifically agonises the serotonin 1F receptor.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics